Marit Health | $3,200,000 | (Apr 1, 2025)
Inspiren | $35,000,000 | (Apr 1, 2025)
BetterFleet | $15,000,000 | (Apr 1, 2025)
Certified by Founder
Lodge
Tome Biosciences
start up
United States
- Watertown, Massachusetts
- 14/12/2023
- Series B
- $213,000,000
Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific precision. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies.
- Industry Biotechnology Research
- Website https://tome.bio/
- LinkedIn https://www.linkedin.com/company/tome-biosciences/about/
Isomorphic Labs | $600,000,000 | (Apr 1, 2025)
Sohar Health (YC S23) | $3,800,000 | (Apr 1, 2025)
Retym, Inc | $75,000,000 | (Apr 1, 2025)
Ribbon | $8,000,000 | (Apr 1, 2025)
DeepIP | $15,000,000 | (Apr 1, 2025)
Kay.ai | $3,000,000 | (Apr 1, 2025)
GridPoint | $45,000,000 | (Apr 1, 2025)
POCKLA | $1,728,856 | (Apr 1, 2025)
mo:re | $2,485,277 | (Apr 1, 2025)